NON-MUSCLE INVASIVE BLADDER CARCINOMA
Clinical trials for NON-MUSCLE INVASIVE BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New bladder cancer drug TARA-002 faces chemotherapy in major trial
Disease control Recruiting nowThis phase 3 trial tests whether a new drug, TARA-002, works better than standard chemotherapy for a type of early-stage bladder cancer. About 284 adults who have not received BCG therapy will be randomly assigned to receive either TARA-002 or chemotherapy directly into the bladd…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE3 • Sponsor: Protara Therapeutics • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Broccoli vs. bladder cancer: could your diet keep tumors away?
Disease control Recruiting nowThis study tests a healthy eating program that encourages people with early-stage bladder cancer to eat more cruciferous vegetables like broccoli, kale, and cabbage. These veggies contain natural compounds that may help fight cancer cells. Researchers want to see if this diet cha…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New bladder cancer drug gets first human test
Disease control Recruiting nowThis early-stage trial is testing a new drug called belzupacap sarotalocan (AU-011) for people with non-muscle-invasive bladder cancer. The drug is injected directly into the tumor, sometimes with a laser. The main goal is to see if this approach is safe and feasible. About 55 pa…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE1 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Bladder cancer chemotherapy comes home: new trial tests convenience and safety
Symptom relief Recruiting nowThis study tests whether giving chemotherapy directly into the bladder at home is safe and acceptable for people with non-muscle invasive bladder cancer. About 40 participants will receive their usual medications—such as BCG, gemcitabine, docetaxel, or mitomycin—at home instead o…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Lying down or sitting up? study tests best position for bladder cancer drug
Knowledge-focused Recruiting nowThis study tests whether a patient's position (lying down, sitting up, or moving freely) affects how long the BCG medicine stays in the bladder during treatment for non-muscle invasive bladder cancer. Researchers will measure dwell time in 40 patients under three different positi…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE4 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC